In one paragraphArticle in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Cecília Alvim DutraAcademic Tuberculosis Program, Faculty of Medicine, HUCFF-IDT Hospital Complex, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
Raquel Lima de Figueiredo TeixeiraLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Márcia Quinhones Pires LopesLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Victória de Moraes SilvaLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Philip Noel SuffysLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Ricardo de Souza CarvalhoDepartment of General Medicine, University of Rio de Janeiro (UniRio), Rio de Janeiro 20270-330, Brazil.
Adriana Rezende MoreiraAcademic Tuberculosis Program, Faculty of Medicine, HUCFF-IDT Hospital Complex, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.ORCID 0000-0001-7057-805X Adalberto Rezende SantosLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-9514-4589 Afrânio Lineu KritskiAcademic Tuberculosis Program, Faculty of Medicine, HUCFF-IDT Hospital Complex, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.ORCID 0000-0002-5900-6007 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The human N-acetyltransferase 2 enzyme, encoded by the
Indexed as
NAT2pharmacogeneticssingle-nucleotide polymorphismstreatmenttuberculosis
Identifiers
PMID39065614
PMCPMC11279449
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390